share_log

石四药集团(02005.HK)：复方电解质注射液(500ml)已取得药监局批准通过仿制药质量和疗效一致性评价

Shisi Pharmaceutical Group (02005.HK): Compound electrolyte injection (500ml) has obtained approval from the Drug Administration to pass the consistent evaluation of the quality and efficacy of generic drugs

Gelonghui Finance ·  May 13 12:05

Gelonghui, May 13, 丨 Shijiyao Group (02005.HK) announced that the Group's compound electrolyte injection (500ml) has obtained approval from China's State Drug Administration to pass the consistent evaluation of the quality and efficacy of generic drugs, which is the second domestic company to be approved.

Compound electrolyte injections are mainly used as a supplementary source of water and electrolytes, and as an alkalizing agent. The compound electrolyte injection is compatible with blood and blood components. The same dosing device can be used to be transfused before or after a blood transfusion (that is, as a prefill), added to the blood component being transfused, or as a diluent for blood cells.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment